Gruppo Farmaimpresa Successfully Concludes CPHI Milan 2024

Thank You for Visiting Our Stand at CPHI Milan Gruppo Farmaimpresa’s participation in CPHI Milan came to a very positive close, marking an important moment for meeting international professionals from the pharmaceutical and nutraceutical industries. The exhibition was a valuable opportunity to present our company as a food supplement and medical device manufacturer, as well…

Gruppo Farmaimpresa at Vitafoods Europe 2024

From May 14 to 16, 2024, Gruppo Farmaimpresa took part in Vitafoods Europe 2024 in Geneva, one of the most important international events dedicated to the nutraceutical and pharmaceutical industries. The exhibition was an important opportunity to present our expertise as a manufacturer of food supplements and medical devices, as well as a reliable partner…

Frequently asked questions in the MDR field

In this article we are going to analyze the questions and answers regarding the new European Regulation 2017/745 or MDR (Medical Device Regulation). Recall that we are among the first Italian companies to have obtained MDR certifications for some of our medical devices.   How are economic operators regulated in the new MDR regulation? In…

MDR regulations: the technical file

When is a change in a medical technical file considered significant under Art. 120(3)MDR? A Medical Device Manufacturer with a valid certificate issued by a Notified Body under Directive 90/385/EEC (AIMDD) or Directive 93/42/EEC (MDD) may place its devices on the market even after May 26, 2021 (date of full implementation of MDR (EU) 2017/745)…